Dr Charles Wykoff, a retina clinician-scientist, explains how recent breakthroughs have added to the joys that come with choosing ophthalmology as a specialty. Medscape Med Students
Tag: Commentary
Do Fluoroquinolones Increase Retinal Detachment Risk?
Experts say contrary results shouldn’t yet change established practices, but further analysis is warranted. Medscape Ophthalmology
Can’t-Miss Highlights in Retina
Catch up on the latest in the diagnosis and management of vitreoretinal diseases, including some of the new and upcoming therapeutic options. Medscape Ophthalmology
6 Major Advances in Ophthalmology
Take a look back at some of the top innovations that advanced the field of ophthalmology in 2016. Medscape Ophthalmology
New Risks Posed by Vancomycin Use in Cataract Surgery
Dr Roger Steinert shares the latest information on hemorrhagic occlusive retinal vasculitis, a new and potentially devastating complication. Medscape Ophthalmology
Current Screening for Congenital CMV: Who Are We Missing?
The majority of infants born with congenital CMV infection are asymptomatic and thus missed with current screening strategies. What are the pros and cons of universal screening? CHOP Expert Commentary
New Guidelines for Hydroxychloroquine Visual Screening
With increasing and broader use of hydroxychloroquine, more patients are in need of ongoing screening for retinal toxicity. Medscape Optometry
Diabetic Neuropathy Screening: More Bang for the Buck
Researchers are finding ways to make annual screening quick, easy, and comprehensive for patients.
Medscape Diabetes & Endocrinology
Two New Corneal Inlays Increase Options for Presbyopia
Dr Roger Steinert discusses the relative merits of both the KAMRA Inlay and the Raindrop Near Vision Inlay. Medscape Ophthalmology
Are Oral Bisphosphonates Associated With Wet AMD?
With the rising prevalence of oral bisphosphonate use and wet age-related macular degeneration, we must ask ourselves if the two are related. Medscape Ophthalmology
As Glaucoma Management Evolves, New Options Abound
Optometrists have been liberated from earlier restrictive management strategies. Now the challenge is in keeping up-to-date with the newest possibilities. Medscape Optometry
A ‘Symfony’ of Hope for Cataract Patients
From distance and near vision to astigmatism and chromatic aberration, the new Symfony intraocular lens seems to correct it all. Wills Eye Hospital
A Game Changer in the Treatment of Dry Eye
Drs Rapuano and Nagra from Wills Eye discuss the recently approved drug lifitegrast (Xiidra), the only one indicated to treat the signs and symptoms of dry eye, and a promising new option for patients. Wills Eye Hospital
Better Than Drugs: A Diabetes Prevention Program That Works
Matt Longjohn, national health officer of the YMCA, describes the very successful diabetes prevention programs administered through the YMCA and deemed reimbursable by CMS. Medscape Family Medicine
Following in My Footsteps: A Dad Reflects on His MD Kids
For Father’s Day, a physician reflects on what it’s like to have raised two future physicians.
Medscape Diabetes & Endocrinology
Added Benefits Seen With Early Initiation of Anti-VEGF Agents for Diabetic Retinopathy
Dr Charles C. Wykoff reviews recent data showing that more timely treatment has a significant upside. Medscape Ophthalmology
5 Key Ophthalmology Takeaways: ASCRS 2016
Attendees in New Orleans were greeted with innovative theories and technologies that may change our treatment of glaucoma, cataracts, corneal ectasia, and other ophthalmic conditions. Medscape Ophthalmology
Corneal Crosslinking: Advancing the Treatment of Keratoconus
Corneal transplantation has been the only curative treatment for progressive keratoconus until now. Drs Rapuano and Feldman discuss a newly approved treatment option that is available. Wills Eye Hospital
Learning to Love Electronic Medical Records
Fighting through autofill errors and drop-down menu frustrations, an optometrist keeps an optimistic outlook on the future of electronic medical records. Medscape Optometry
Reaching a Milestone in the Treatment of Keratoconus
The recent approval of corneal crosslinking by the FDA is an important step forward in the treatment of keratoconus. Dr Roger Steinert offers commentary. Medscape Ophthalmology